Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
67,604,359
-
Total 13F shares
-
58,446,117
-
Share change
-
+3,033,436
-
Total reported value
-
$5,592,182,203
-
Put/Call ratio
-
53%
-
Price per share
-
$95.68
-
Number of holders
-
292
-
Value change
-
+$257,661,607
-
Number of buys
-
141
-
Number of sells
-
158
Institutional Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q4 2020
As of 31 Dec 2020,
TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) was held by
292 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
58,446,117 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, BlackRock Inc., Jackson Square Partners, LLC, Capital World Investors, WELLINGTON MANAGEMENT GROUP LLP, Invesco Ltd., CREDIT SUISSE AG/, GILDER GAGNON HOWE & CO LLC, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
292
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.